Quarterly Result

Lyka Labs Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln)

BSE Code: 500259

ISIN Demat: INE933A01014

Book Value(₹): 37.02

NSE Symbol: LYKALABS

Div & Yield(%): N.A

Market Cap(₹ Cr): 220.39

P/E(TTM): N.A


EPS(TTM): N.A


Face Value(₹): 10.00

Particulars Dec 2025 (₹ Cr) Sep 2025 (₹ Cr) Jun 2025 (₹ Cr)
Gross Sales 30.73 32.97 29.18
Excise Duty 0.00 0.00 0.00
Net Sales 30.73 32.97 29.18
Other Operating Income 0.00 0.00 0.00
Other Income 1.26 1.21 0.67
Total Income 31.99 34.19 29.84
Total Expenditure 28.82 36.12 25.79
PBIDT 3.17 -1.94 4.06
Interest 0.82 0.79 0.85
PBDT 2.35 -2.73 3.20
Depreciation 2.08 2.07 2.03
Tax 0.00 0.18 0.31
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 0.00 -1.35 0.05
Reported Profit After Tax 0.28 -3.63 0.81
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 0.28 -3.63 0.81
EPS (Unit Curr.) 0.08 -1.02 0.22
EPS (Adj) (Unit Curr.) 0.08 -1.02 0.22
Calculated EPS (Unit Curr.) 0.08 -1.02 0.23
Calculated EPS (Adj) (Unit Curr.) 0.08 -1.02 0.23
Calculated EPS (Ann.) (Unit Curr.) 0.31 -4.06 0.91
Calculated EPS (Adj) (Ann.) (Unit Curr.) 0.31 -4.06 0.91
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 35.69 35.69 35.69
Reserve & Surplus 0.00 0.00 0.00
Face Value 10.00 10.00 10.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 10.32 -5.88 13.91
PBDTM(%) 7.65 -8.28 10.97
PATM(%) 0.91 -11.01 2.78
Attention Investor :
Prevent Unauthorised Transactions in your Trading / Demat account --> Update your Mobile Number with your Depository Participant